64 results on '"Correa-Rotter, Ricardo"'
Search Results
2. Dietary inflammatory index and lower glomerular filtration rate in Mexican adults
3. Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study
4. Association between soft drinks intake and low glomerular filtration rate in Mexican adults: Results from RenMex
5. Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria
6. Projecting the Population Level Burden of CKD Progression According to Urine Albumin-to-Creatinine Ratio Categories
7. Representation of Low- and Middle-Income Countries in CKD Drug Trials: A Systematic Review
8. Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis
9. Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure
10. Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions
11. The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists
12. Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials
13. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
14. Frequency of Intradialytic Hypotension Events Do Not Increase with Oral Nutritional Supplementation during Hemodialysis Treatment: A Randomized Controlled Trial
15. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
16. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
17. Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure
18. A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy
19. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
20. Correction of anemia by dapagliflozin in patients with type 2 diabetes
21. Mesoamerican Nephropathy
22. Chronic kidney disease after acute kidney injury associated with intravenous colistin use in survivors of severe infections: A comparative cohort study
23. Mind the gap in kidney care: translating what we know into what we do
24. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
25. Nefropatía mesoamericana: revisión breve basada en el segundo taller del Consorcio para el estudio de la Epidemia de Nefropatía en Centroamérica y México (CENCAM)
26. Dissonant health transition in the states of Mexico, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
27. Unmet Needs of CKD in Latin America: A Review from Expert Virtual Working Group
28. CKD of Unknown Origin in Central America: The Case for a Mesoamerican Nephropathy
29. Angiogenic and inflammatory markers in acute respiratory distress syndrome and renal injury associated to A/H1N1 virus infection
30. Mind the Gap in Kidney Care: Translating What We Know into What We Do
31. The authors reply
32. WCN24-1229 EFFECTS OF TREATMENT AND CLINICAL EVENTS ON QUALITY OF LIFE IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A PRESPECIFIED ANALYSIS OF THE DAPA-CKD TRIAL
33. WCN24-890 INSIDE CKD - PRAGMATIC LITERATURE REVIEWS TO POPULATE A PATIENT-LEVEL MODEL TO PROJECT THE FUTURE CLINICAL BURDEN OF CKD IN FOUR LOW- AND MIDDLE INCOME COUNTRIES
34. WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY
35. WCN24-2243 GERIATRIC SYNDROMES AND DECISION MAKING IN PATIENTS REFERRED TO A GERIATRIC NEPHROLOGY CLINIC
36. WCN24-1464 MEASUREMENT OF CEREBRAL BLOOD FLOW USING TRANSCRANIAL DOPPLER ULTRASOUND: COMPARISON OF TWO POPULATIONS OF PATIENTS IN CHRONIC HEMODIALYSIS
37. Risk factors for infections requiring hospitalization in renal transplant recipients: a cohort study
38. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate
39. 38 - Diálisis peritoneal en situaciones especiales
40. 21 - Defensas peritoneales
41. 17 - Evaluación de la dosis adecuada de diálisis
42. 64 - Peritoneal Dialysis
43. Chapter 9 - Ethnicity and Chronic Kidney Disease in Disadvantaged Populations—An International Perspective
44. Challenges and opportunities in interventions for chronic kidney disease of unknown origin (CKDu): report from the International Society of Nephrology Consortium of Collaborators on CKDu
45. A Soy Protein Diet Alters Hepatic Lipid Metabolism Gene Expression and Reduces Serum Lipids and Renal Fibrogenic Cytokines in Rats with Chronic Nephrotic Syndrome
46. Chapter 22 - Mesoamerican Nephropathy or Chronic Kidney Disease of Unknown Origin
47. Data from a pooled post hoc analysis of 14 placebo-controlled, dapagliflozin treatment studies in patients with type 2 diabetes with and without anemia at baseline
48. Colaboradores
49. Creatinine Versus Cystatin C for Estimating GFR in Patients With Liver Cirrhosis
50. Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.